1. Megen van, H.J., Westenberg, H.G., Den Boer, J.A., and Kahn, R.S., The Panic-Inducing Properties of the Cholecystokinin Tetrapeptide CCK4 in Patients with Panic Disorder, Eur Neuropsychopharmacol., 1996, vol. 6, no. 3, pp. 187–194.
2. Megen van, H.J., Westenberg, H.G., Den Boer, J.A., et al., Effect of the Selective Serotonin Reuptake Inhibitor Fluvoxamine on CCK-4 Induced Panic Attacks, Psychopharmacology (Berl)., 1997, vol. 129, no. 4, pp. 357–364.
3. Adan, A.H., Oosterom, J., Ludvigsdottir, G., et al., Identification of Antagonists for Melanocortin MC3, MC4 and MC5 Receptors, Eur. J. Pharmacol., 1994, vol. 269, pp. 331–337.
4. Ashmarin, I.P., Nezavibatko, V.N., Myasoedov, N.F., et al., Nootropic Analog of Adrenocorticotropic Hormone 4–10, Semax: Fifteen-Year Experience of Development, Zh. Vyssh. Nervn. Deyat. im. I.P. Pavlova, 1997, vol. 47, no. 2, pp. 420–430.
5. Ashmarin, I.P., Nezavibatko, V.N., Levitskaya, N.G., et al., Design and Investigation of an ACTH(4–10) Analogue Lacking D-Amino Acids and Hydrophobic Radicals, Neurosci. Res. Commun., 1995, vol. 16, no. 2, pp. 105–112.